Evolution of the Average Target: Harmonic Inc.

Evolution of the Target Price: Harmonic Inc.

Changes in Analyst Recommendations: Harmonic Inc.

4e.QaLfGZvxBfwk4gMWdKoEoTtNzx79weCHHMZnRZK_atY.c_DvTtCccrAdslpuQZ022Gp1_XC2kbbvLLxWdKbMGLss6pBu7a5wvx2yMw~319009247706115cdfe84a9634159a19
16/01 Top Midday Stories: BlackRock Rises on Q4 Results; Amazon Challenges Saks Global Chapter 11 Plan; Ford-BYD Potential Deal MT
29/07/25 Harmonic Q2 revenue, adjusted EPS beat expectations RE
08/07/25 Wolfe Initiates Harmonic at Underperform With $7 Price Target MT
11/01/25 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
09/01/25 Barclays Downgrades Harmonic to Equalweight From Overweight, Adjusts Price Target to $14 From $17 MT
30/10/24 Jefferies Downgrades Harmonic to Hold From Buy, Price Target is $12.50 MT
29/10/24 Raymond James Downgrades Harmonic to Outperform From Strong Buy, Price Target is $14 MT
31/01/24 Raymond James Trims Price Target on Harmonic to $18 From $19, Maintains Strong Buy Rating MT
31/01/24 Rosenblatt Securities Cuts Harmonic Price Target to $16 From $18, Maintains Buy Rating MT
02/11/23 Barclays Adjusts Price Target on Harmonic to $14 From $20, Maintains Overweight Rating MT
10/08/23 Raymond James Upgrades Harmonic to Strong Buy From Outperform, Adjusts Price Target to $16 From $15 MT
01/08/23 Jefferies Adjusts Harmonic Price Target to $18 From $19, Maintains Buy Rating MT
01/08/23 Raymond James Adjusts Price Target on Harmonic to $15 From $17, Maintains Outperform Rating MT
01/08/23 Rosenblatt Securities Adjusts Harmonic Price Target to $18 From $22, Maintains Buy Rating MT
01/08/23 Needham Adjusts Harmonic's Price Target to $18 From $21, Keeps Buy Rating MT
01/08/23 Barclays Adjusts Harmonic's Price Target to $20 From $23, Keeps Overweight Rating MT
09/05/23 Rosenblatt Adjusts Price Target on Harmonic to $22 From $20, Maintains Buy Rating MT
09/05/23 Barclays Adjusts Price Target on Harmonic to $23 From $20, Keeps Overweight Rating MT
22/03/23 Northland Securities Adjusts Price Target on Harmonic to $23 From $20, Keeps Outperform Rating MT
31/01/23 Raymond James Adjusts Harmonic Price Target to $17 From $18, Maintains Outperform Rating MT
31/01/23 Barclays Adjusts Harmonic's Price Target to $20 From $17, Keeps Overweight Rating MT
25/01/23 Needham Adjusts Price Target on Harmonic to $19 From $17, Maintains Buy Rating MT
09/01/23 Jefferies Upgrades Harmonic to Buy From Hold, Price Target is $19 MT
17/12/22 LifeSci Capital Downgrades Third Harmonic Bio to Market Perform From Outperform MT
17/12/22 Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Slashes Price Target to $5 From $34 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+28.53%
+23.06%
+29.69%
+48.28%
+45.61%
+38.75%
+8.71%
+15.95%
+40.96%
-1.82%
Average +27.77%
Weighted average by Cap. +29.71%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12.56USD
Average target price
16.14USD
Spread / Average Target
+28.53%
High Price Target
20.00USD
Spread / Highest target
+59.24%
Low Price Target
8.000USD
Spread / Lowest Target
-36.31%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wolfe Research
Barclays
Jefferies & Co.
Raymond James
Rosenblatt Securities
Needham & Co.
Northland Securities
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12.56USD
Average target price
16.14USD
Spread / Average Target
+28.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HLIT Stock
  4. Consensus Harmonic Inc.